Engineers Gate Manager LP Karuna Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $772,986 - $1.05 Million	4,384 New	4,384 $950,000
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $1.64 Million - $2.03 Million	-8,565 Reduced 73.88%	3,028 $595,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $1.15 Million - $2.57 Million	9,263 Added 397.55%	11,593 $2.61 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $29,130 - $44,432	310 Added 15.35%	2,330 $295,000
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $199,778 - $267,387	2,020 New	2,020 $256,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.